2CUREX AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.446 SEK | -5.11% |
|
+11.50% | -77.81% |
| Feb. 29 | 2curex AB Elects Grith Hagel as a New Board Member | CI |
| Feb. 22 | 2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 63.65 | 147.2 | 169.5 | 245.7 | 293.6 | 143.5 |
| Enterprise Value (EV) 1 | 43.67 | 127.1 | 135.8 | 187.1 | 220.7 | 98.57 |
| P/E ratio | -16.5 x | -20.3 x | -20 x | -30.8 x | -14.6 x | -4.81 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 16.3 x | 19.2 x | 14.1 x | 16 x | 39.7 x | 42.6 x |
| EV / Revenue | 11.2 x | 16.6 x | 11.3 x | 12.2 x | 29.9 x | 29.3 x |
| EV / EBITDA | -11.9 x | -15.9 x | -16.3 x | -26.6 x | -9.83 x | -3.1 x |
| EV / FCF | -11.7 x | 65.9 x | -21.4 x | -18.1 x | -16.5 x | -6.35 x |
| FCF Yield | -8.56% | 1.52% | -4.67% | -5.53% | -6.07% | -15.8% |
| Price to Book | 3.15 x | 10.8 x | 6.04 x | 4.18 x | 3.95 x | 3.33 x |
| Nbr of stocks (in thousands) | 10,350 | 10,350 | 12,420 | 14,846 | 17,476 | 17,603 |
| Reference price 2 | 6.150 | 14.22 | 13.65 | 16.55 | 16.80 | 8.150 |
| Announcement Date | 5/7/18 | 5/7/19 | 5/7/20 | 5/6/21 | 5/3/22 | 4/20/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3.903 | 7.675 | 11.98 | 15.39 | 7.391 | 3.369 |
| EBITDA 1 | -3.683 | -8.005 | -8.313 | -7.032 | -22.45 | -31.82 |
| EBIT 1 | -3.973 | -8.436 | -8.749 | -7.418 | -22.8 | -32.13 |
| Operating Margin | -101.79% | -109.92% | -73.02% | -48.2% | -308.5% | -953.78% |
| Earnings before Tax (EBT) 1 | -3.995 | -8.542 | -9.411 | -8.591 | -22.48 | -29.77 |
| Net income 1 | -3.136 | -7.264 | -7.933 | -7.32 | -18.94 | -29.77 |
| Net margin | -80.35% | -94.64% | -66.21% | -47.56% | -256.22% | -883.64% |
| EPS 2 | -0.3719 | -0.7018 | -0.6833 | -0.5380 | -1.153 | -1.693 |
| Free Cash Flow 1 | -3.739 | 1.93 | -6.337 | -10.35 | -13.39 | -15.53 |
| FCF margin | -95.79% | 25.15% | -52.89% | -67.27% | -181.13% | -461.06% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/7/18 | 5/7/19 | 5/7/20 | 5/6/21 | 5/3/22 | 4/20/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 20 | 20.1 | 33.7 | 58.6 | 72.9 | 44.9 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -3.74 | 1.93 | -6.34 | -10.4 | -13.4 | -15.5 |
| ROE (net income / shareholders' equity) | -23.4% | -42.9% | -38.1% | -16.8% | -28.4% | -50.7% |
| ROA (Net income/ Total Assets) | -15.1% | -22.5% | -17.7% | -9.19% | -20% | -31.7% |
| Assets 1 | 20.79 | 32.29 | 44.88 | 79.64 | 94.48 | 93.99 |
| Book Value Per Share 2 | 1.960 | 1.320 | 2.260 | 3.960 | 4.250 | 2.440 |
| Cash Flow per Share 2 | 1.930 | 1.940 | 2.710 | 3.940 | 4.170 | 2.550 |
| Capex 1 | 0.01 | 1.2 | 0.06 | 0.4 | 0.03 | 0.54 |
| Capex / Sales | 0.18% | 15.61% | 0.49% | 2.62% | 0.43% | 16.06% |
| Announcement Date | 5/7/18 | 5/7/19 | 5/7/20 | 5/6/21 | 5/3/22 | 4/20/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -77.81% | 716K | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 383M |
- Stock Market
- Equities
- 2CUREX Stock
- Financials 2cureX AB
